CARPAGNANO, GIOVANNA ELISIANA
 Distribuzione geografica
Continente #
NA - Nord America 8.817
AS - Asia 4.415
EU - Europa 3.819
SA - Sud America 1.129
AF - Africa 228
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 4
Totale 18.418
Nazione #
US - Stati Uniti d'America 8.604
SG - Singapore 1.939
IT - Italia 1.387
BR - Brasile 860
CN - Cina 716
HK - Hong Kong 584
RU - Federazione Russa 479
SE - Svezia 451
DE - Germania 349
VN - Vietnam 330
FR - Francia 313
FI - Finlandia 229
GB - Regno Unito 215
IN - India 177
BD - Bangladesh 171
CA - Canada 109
AR - Argentina 83
UA - Ucraina 81
IQ - Iraq 71
ID - Indonesia 68
MX - Messico 63
CI - Costa d'Avorio 62
NL - Olanda 59
PL - Polonia 57
ZA - Sudafrica 55
JP - Giappone 42
VE - Venezuela 42
EC - Ecuador 41
TR - Turchia 41
PK - Pakistan 40
CO - Colombia 36
SA - Arabia Saudita 35
AT - Austria 33
UZ - Uzbekistan 31
CZ - Repubblica Ceca 28
MA - Marocco 27
ES - Italia 26
MY - Malesia 26
IE - Irlanda 25
PH - Filippine 25
LT - Lituania 24
CL - Cile 20
EG - Egitto 19
PY - Paraguay 17
BE - Belgio 16
NP - Nepal 15
BO - Bolivia 14
JO - Giordania 14
KE - Kenya 14
TN - Tunisia 13
AE - Emirati Arabi Uniti 11
CH - Svizzera 10
IL - Israele 10
UY - Uruguay 10
KZ - Kazakistan 9
AZ - Azerbaigian 8
DZ - Algeria 8
JM - Giamaica 8
ET - Etiopia 7
PT - Portogallo 7
TH - Thailandia 7
GR - Grecia 6
IR - Iran 6
NI - Nicaragua 6
OM - Oman 6
PA - Panama 6
PE - Perù 6
SN - Senegal 6
BH - Bahrain 5
CR - Costa Rica 5
HN - Honduras 5
TT - Trinidad e Tobago 5
AU - Australia 4
LB - Libano 4
RS - Serbia 4
AL - Albania 3
DK - Danimarca 3
GE - Georgia 3
HR - Croazia 3
KG - Kirghizistan 3
NG - Nigeria 3
PS - Palestinian Territory 3
SC - Seychelles 3
BN - Brunei Darussalam 2
BW - Botswana 2
EE - Estonia 2
HU - Ungheria 2
KR - Corea 2
MN - Mongolia 2
RO - Romania 2
SY - Repubblica araba siriana 2
XK - ???statistics.table.value.countryCode.XK??? 2
AO - Angola 1
BG - Bulgaria 1
BJ - Benin 1
BS - Bahamas 1
BY - Bielorussia 1
CG - Congo 1
CW - ???statistics.table.value.countryCode.CW??? 1
CY - Cipro 1
Totale 18.395
Città #
Ashburn 1.188
Singapore 1.014
Fairfield 787
San Jose 647
Hong Kong 580
Chandler 534
Milan 480
Woodbridge 440
Nyköping 354
Seattle 342
Houston 311
Cambridge 287
Wilmington 254
Beijing 214
New York 207
Dallas 194
Los Angeles 190
Helsinki 182
Rome 177
Lauterbourg 171
Jacksonville 146
Lawrence 142
Roxbury 126
Council Bluffs 123
Ann Arbor 120
Munich 108
Des Moines 93
Ho Chi Minh City 93
São Paulo 91
Boardman 80
Columbus 78
Santa Clara 77
Hanoi 66
Falkenstein 65
Bari 64
London 64
Buffalo 63
Chicago 63
Abidjan 62
Inglewood 62
San Diego 62
Paris 54
Figino 53
Frankfurt am Main 53
Warsaw 49
Brooklyn 48
Jakarta 41
Tokyo 41
Orem 40
Montreal 39
Dearborn 38
Nuremberg 37
Nanjing 36
Atlanta 34
Naples 33
Baghdad 32
Princeton 32
Denver 30
Dong Ket 29
Stockholm 29
Turin 29
Johannesburg 28
Chennai 27
Rio de Janeiro 27
Mexico City 25
Tashkent 25
Toronto 25
San Francisco 24
Brasília 22
Poplar 22
Guangzhou 21
Belo Horizonte 20
Da Nang 20
Dublin 20
Riyadh 19
Kuala Lumpur 18
Moscow 17
Brussels 16
Manchester 16
Salt Lake City 16
Shanghai 16
Buenos Aires 15
Turku 15
Amsterdam 14
Charlotte 14
Medellín 14
Olomouc 14
Phoenix 14
Pune 14
Washington 14
Boston 13
Istanbul 13
Amman 12
Ankara 12
Haiphong 12
Hebei 12
New Delhi 12
Norwalk 12
Shenyang 12
Vienna 12
Totale 11.852
Nome #
"Malattie dell’apparato respiratorio. Pneumologia e chirurgia toracica" 268
A survey of fungal microbiota in airways of healthy volunteer subjects from Puglia (Apulia), Italy 208
Application of machine learning to predict obstructive sleep apnea syndrome severity 205
3p microsatellite alterations in exhaled breath condensate from patients with non-small cell lung cancer 171
Assessment of Induced Sputum Cellularity in COPD Patients Belonging to Two Different Classes of Air Pollution Exposure 170
Airway inflammation in subjects with gastro-oesophageal reflux and gastro-oesophageal reflux-related asthma 164
Oxygen therapy at low flow causes oxidative stress in chronic obstructive pulmonary disease: Prevention by N-acetyl cysteine 162
8-Isoprostane, a marker of oxidative stress, is increased in exhaled breath condensate of patients with obstructive sleep apnea after night and is reduced by continuous positive airway pressure therapy 148
Relationship Between Oral Lesions and Severe SARS-CoV-2 Infection in Intensive Care Unit Patients 146
Vitamin D deficiency as a predictor of poor prognosis in patients with acute respiratory failure due to COVID-19 142
Gender difference in sleep profile of severely obese patients with obstructive sleep apnea (OSA) 138
The importance of maintaining the same order of performance of lung function and SNIP tests in patients with amyotrophic lateral sclerosis 138
Severe uncontrolled asthma with bronchiectasis: A pilot study of an emerging phenotype that responds to mepolizumab 137
A European respiratory society technical standard: Exhaled biomarkers in lung disease 134
Interleukin-6 is increased in breath condensate of patients with non-small cell lung cancer. 133
Bamlanivimab and Etesevimab administered in an outpatient setting for SARS-CoV-2 infection 133
COVID-19 as a Paradigmatic Model of the Heterogeneous Disease Presentation in Older People: Data from the GeroCovid Observational Study 131
Effectiveness and safety of anti-IL-5/Rα biologics in eosinophilic granulomatosis with polyangiitis: a two-year multicenter observational study 131
Exhaled Interleukine-6 and 8-isoprostane in chronic obstructive pulmonary disease: effect of carbocysteine lysine salt monohydrate (SCMC-Lys) 130
Omalizumab as add-on therapy in a patient with severe asthma and OSA 130
Mucopenetration study of solid lipid nanoparticles containing magneto sensitive iron oxide 126
Exhaled inflammatory markers in aspirin-induced asthma syndrome. 124
Increased 8-isoprostane and interleukin-6 in breath condensate of obstructive sleep apnea patients 123
Clinical profile of trazodone users in a multisetting older population: data from the Italian GeroCovid Observational study 122
Gender, age and menopause effects on the prevalence and the characteristics of obstructive sleep apnea in obesity. 122
Switching from omalizumab to mepolizumab: real-life experience from Southern Italy 122
Supplementary oxygen in healthy subjects and those with COPD increases oxidative stress and airway inflammation 121
Transthoracic ultrasound sign in severe asthmatic patients: a lack of "gliding sign" mimic pneumothorax 121
Oral CorticoSteroid sparing with biologics in severe asthma: A remark of the Severe Asthma Network in Italy (SANI) 119
A glimpse in post-COVID pathophysiology: the role of exhaled breath condensate pH as an early marker of residual alveolar inflammation 118
Increased IL-6 and IL-4 in exhaled breath condensate of patients with nasal polyposis 118
Changes in sputum composition during 15 min of sputum induction in healthy subjects and patients with asthma and chronic obstructive pulmonary disease 116
Incidence of deep venous thrombosis in patients with both pulmonary embolism and copd 116
Analysis of mitochondrial DNA alteration in new phenotype ACOS 115
Influence of subclinical hypothyroidism and T4 treatment on the prevalence and severity of obstructive sleep apnoea syndrome (OSAS) 114
Airway inflammation in patients affected by obstructive sleep apnea syndrome 114
Higher blood eosinophil levels after omalizumab treatment may be associated with poorer asthma outcomes 114
The role of obstructive sleep apnea syndrome and obesity in determining leptin in the exhaled breath condensate 113
A New SERPINA-1 Missense Mutation Associated with Alpha-1 Antitrypsin Deficiency and Bronchiectasis 113
Body mass index, airflow obstruction, dyspnea, and exercise index is not modified after 6 months therapy with roflumilast in a cohort of patients with chronic obstructive pulmonary disease 112
Predictive equations for CPAP titration in OSAS patients 111
Aging and airway inflammation 111
Physical activity as a new tool to evaluate the response to omalizumab and mepolizumab in severe asthmatic patients: A pilot study 110
The association between dysphagia and OSA Disfagia e OSA 110
Validity and reproducibility of morphologic analysis of nasal secretions obtained using ultrasonic nebulization of hypertonic solution. 109
Menopausal asthma: a new biological phenotype? 108
Exhaled Nitric Oxide and Exhaled Breath Temperature as Potential Biomarkers in Patients with Pulmonary Hypertension 108
Analysis of the fungal microbiome in exhaled breath condensate of patients with asthma 107
The potential role of endothelial dysfunction and platelet activation in the development of thrombotic risk in COPD patients 105
Evidence of lower oxidative stress in the air spaces of patients with reversible COPD 105
Is the Exhaled Breath Temperature Sensitive to Cigarette Smoking? 105
Searching for Inflammatory and Oxidative Stress Markers Capable of Clustering Severe Asthma 105
Exhaled Breath Condensate (EBC) for SARS-CoV-2 diagnosis still an open debate 105
Correlation between nasal inflammation assessed by nasal cytology and blood neutrophil-to-lymphocyte ratio in patients with copd 104
3p microsatellite signature in exhaled breath condensate and tumor tissue of patients with lung cancer 104
Fractional Exhaled Nitric Oxide (FENO) in the management of asthma: a position paper of the Italian Respiratory Society (SIP/IRS) and Italian Society of Allergy, Asthma and Clinical Immunology (SIAAIC) 104
Clinical features associated with a doctor-diagnosis of bronchiectasis in the Severe Asthma Network in Italy (SANI) registry 104
The Role of a Polymer-Based E-Nose in the Detection of Head and Neck Cancer from Exhaled Breath 103
Role of plasmatic leptin in response to hypercapnia in obese patients with or without osas 103
MicroRNA expression profile during different conditions of hypoxia 103
Short-term Tezepelumab effectiveness in patients with severe asthma: a multicentre study 102
Coexistent Sarcoidosis and Tuberculosis: A Case Report 102
Advancing Care in Severe Asthma: The Art of Switching Biologics 101
Aspergillus spp. colonization in exhaled breath condensate of lung cancer patients from Puglia Region of Italy 100
Prevalence of comorbidities in patients with obstructive sleep apnea syndrome, overlap syndrome and obesity hypoventilation syndrome 99
Mitochondrial DNA alteration in obstructive sleep apnea 99
Exhaled Volatile Organic Compounds analysis by e-nose can detect Idiopathic Pulmonary Fibrosis 99
The Role of Airways 17β-Estradiol as a Biomarker of Severity in Postmenopausal Asthma: A Pilot Study 99
Effect of single session receptive music therapy on anxiety and vital parameters in hospitalized Covid-19 patients: a randomized controlled trial 98
Could neutrophilic airway inflammation in obese people be more due to obstructive sleep apnoea syndrome than to asthma? 98
Could exhaled ferritin and SOD be used as markers for lung cancer and prognosis prediction purposes? 98
Is the exhaled breath temperature in lung cancer influenced by airways neoangiogenesis or by inflammation? 98
High Level of Blood Eosinophils and Localization of Bronchiectasis in Patients with Severe Asthma: A Pilot Study 97
Association between exhaled nitric oxide and nasal polyposis in severe asthma 97
Study of mitochondrial DNA alteration in the exhaled breath condensate of patients affected by obstructive lung diseases 97
Clinical presentation and prognosis of COVID-19 in older adults with hypothyroidism: data from the GeroCovid observational study 96
Evaluation of adiponectin profile in Italian patients affected by obstructive sleep apnea syndrome 96
Use of exhaled breath condensate in the study of airway inflammation after hypertonic saline solution challenge 95
Effectiveness of benralizumab in severe eosinophilic asthma: Distinct sub-phenotypes of response identified by cluster analysis 95
Predictive machine learning models and survival analysis for covid-19 prognosis based on hematochemical parameters 95
Exhaled matrix metalloproteinase-9 in lung cancer 94
Lung ultrasonography for long-term follow-up of COVID-19 survivors compared to chest CT scan 94
Risk factors for transfer from Respiratory Intermediate Care Unit to Intensive Care Unit in COVID-19 94
Treatment response according to small airways disease status: The effects of high-strength extrafine pMDI beclomethasone dipropionate/formoterol fumarate in fixed dose combination in moderate uncontrolled asthmatic patients 94
Cluster Analysis Identifies Patients With Severe Eosinophilic Asthma Who Achieve Super-Response and Remission With Mepolizumab 93
Exhaled markers in the monitoring of airways inflammation and its response to steroid's treatment in mild persistent asthma 93
HPV in exhaled breath condensate of lung cancer patients 93
Endothelial dysfunction assessment by noninvasive peripheral arterial tonometry in patients with chronic obstructive pulmonary disease compared with healthy subjects 93
Characterization of obstructive sleep apnea–hypopnea syndrome (OSA) population by means of cluster analysis 92
How strong is the association between IPF and lung cancer? An answer from airway’s DNA 92
Assessment of Five Questionnaires for Chronic Obstructive Pulmonary Disease in a Southern Italian Population: A Proof-of-Concept Study 91
Use of the exhaled breath condensate in the study of airway inflammation after hypertonic saline challenge 90
Exhaled ERCC-1 and ERCC-2 microsatellite alterations in NSCLC patients 90
Impact of a Pro-Active Infectious Disease Consultation on the Management of a Multidrug-Resistant Organisms Outbreak in a COVID-19 Hospital: A Three-Months Quasi-Experimental Study 89
Nailfold capillaroscopic findings in systemic sclerosis related lung fibrosis and in idiopathic lung fibrosis 89
Cigarette smoke and increased COX-2 and survivin levels in exhaled breath condensate of lung cancer patients: How hot is the link? 89
Managing Small Airway Disease in Patients with Severe Asthma: Transitioning from the “Silent Zone” to Achieving “Quiet Asthma” 88
Dyspnea perception in asthma: Role of airways inflammation, age and emotional status 88
Exhaled breath temperature in NSCLC: Could be a new non-invasive marker? 88
Assessment of eosinophilic nasal inflammation in patients with severe asthma and nasal polyposis before and after six months of therapy with Benralizumab 87
Totale 11.388
Categoria #
all - tutte 93.072
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 93.072


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022947 58 43 3 23 41 115 50 49 110 53 185 217
2022/20231.477 189 211 96 86 145 218 41 153 246 11 49 32
2023/2024708 45 125 52 55 93 172 23 25 17 19 9 73
2024/20253.528 117 59 198 115 110 369 320 340 133 203 509 1.055
2025/20268.872 1.184 349 521 810 1.045 524 1.004 255 982 810 426 962
2026/2027234 234 0 0 0 0 0 0 0 0 0 0 0
Totale 19.022